Insider Stock Trading History of Goldwyn Martin M


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Goldwyn Martin M since year 2005. The trader's CIK number is 1186837. At the time of this reporting, Goldwyn Martin M is the Director of Hi Tech Pharmacal Co Inc . (stock ticker symbol HITK). See this page for all insider trading activities at Hi Tech Pharmacal Co Inc .


Stock purchases, sales, and option exercises reported by insider Goldwyn Martin M since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-10-04 HITK Hi Tech Pharmacal Co Inc Sale 1,500 43.10 64,650
2013-10-04 HITK Hi Tech Pharmacal Co Inc Option Ex 1,500 24.95 37,425
2013-09-27 HITK Hi Tech Pharmacal Co Inc Option Ex 7,308 19.22 140,496
2013-09-27 HITK Hi Tech Pharmacal Co Inc Sale 3,000 43.10 129,300
2013-09-30 HITK Hi Tech Pharmacal Co Inc Option Ex 3,111 13.50 41,998
2012-11-14 HITK Hi Tech Pharmacal Co Inc Option Ex 2,832 8.31 23,533
2012-10-16 HITK Hi Tech Pharmacal Co Inc Option Ex 421 19.59 8,247
2012-07-17 HITK Hi Tech Pharmacal Co Inc Sale 401 32.05 12,852
2012-07-13 HITK Hi Tech Pharmacal Co Inc Option Ex 1,406 8.31 11,683
2012-07-16 HITK Hi Tech Pharmacal Co Inc Sale 5,956 30.97 184,457
2012-07-17 HITK Hi Tech Pharmacal Co Inc Option Ex 401 14.99 6,010
2012-07-16 HITK Hi Tech Pharmacal Co Inc Option Ex 5,956 14.24 84,843
2011-10-10 HITK Hi Tech Pharmacal Co Inc Option Ex 2,595 4.29 11,132
2010-10-05 HITK Hi Tech Pharmacal Co Inc Option Ex 2,512 8.31 20,874
2010-10-06 HITK Hi Tech Pharmacal Co Inc Option Ex 2,290 8.90 20,369
2010-10-06 HITK Hi Tech Pharmacal Co Inc Sale 1,000 21.22 21,220
2010-09-21 HITK Hi Tech Pharmacal Co Inc Option Ex 947 5.83 5,521
2010-09-20 HITK Hi Tech Pharmacal Co Inc Sale 1,000 20.84 20,840
2010-09-20 HITK Hi Tech Pharmacal Co Inc Option Ex 1,000 13.50 13,500
2010-09-16 HITK Hi Tech Pharmacal Co Inc Option Ex 2,358 1.92 4,527
2010-09-13 HITK Hi Tech Pharmacal Co Inc Sale 1,956 20.22 39,550
2010-09-13 HITK Hi Tech Pharmacal Co Inc Option Ex 1,956 10.93 21,379
2010-07-16 HITK Hi Tech Pharmacal Co Inc Option Ex 3,000 10.93 32,790
2010-07-16 HITK Hi Tech Pharmacal Co Inc Sale 3,000 20.46 61,380
2010-04-14 HITK Hi Tech Pharmacal Co Inc Option Ex 466 1.92 894
2010-04-09 HITK Hi Tech Pharmacal Co Inc Sale 1,000 22.65 22,650
2010-04-07 HITK Hi Tech Pharmacal Co Inc Sale 1,750 22.59 39,532
2010-04-09 HITK Hi Tech Pharmacal Co Inc Option Ex 1,000 13.50 13,500
2010-04-07 HITK Hi Tech Pharmacal Co Inc Option Ex 1,750 8.31 14,542
2009-09-30 HITK Hi Tech Pharmacal Co Inc Sale 1,000 22.11 22,110
2009-09-30 HITK Hi Tech Pharmacal Co Inc Option Ex 1,000 8.31 8,310
2009-09-14 HITK Hi Tech Pharmacal Co Inc Sale 2,000 20.82 41,640
2009-09-15 HITK Hi Tech Pharmacal Co Inc Option Ex 3,980 3.10 12,357
2009-09-14 HITK Hi Tech Pharmacal Co Inc Option Ex 2,000 8.31 16,620
2009-09-11 HITK Hi Tech Pharmacal Co Inc Sale 4,811 21.31 102,522
2009-09-11 HITK Hi Tech Pharmacal Co Inc Option Ex 4,811 6.30 30,309
2009-07-16 HITK Hi Tech Pharmacal Co Inc Option Ex 1,652 2.00 3,304
2007-10-11 HITK Hi Tech Pharmacal Co Inc Option Ex 1,417 2.39 3,386
2006-03-16 HITK Hi Tech Pharmacal Co Inc Option Ex 1,523 2.20 3,342
2006-03-15 HITK Hi Tech Pharmacal Co Inc Option Ex 1,500 4.29 6,435
2006-03-15 HITK Hi Tech Pharmacal Co Inc Sale 1,746 27.25 47,578
2006-01-05 HITK Hi Tech Pharmacal Co Inc Option Ex 1,250 6.43 8,041
2006-01-06 HITK Hi Tech Pharmacal Co Inc Option Ex 1,814 3.29 5,971
2006-01-05 HITK Hi Tech Pharmacal Co Inc Sale 1,250 44.32 55,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goldwyn Martin M (Director of Hi Tech Pharmacal Co Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.